Nikki Hancocks

Four weeks of high-dose collagen peptide (CP) supplementation may favorably modulate bone formation and inflammation in female endurance athletes, according to a newly published pilot study.

France has banned CBD edibles and convinced the European Chemicals Agency (ECHA) that CBD should be treated as a reproductive toxicant, adding pressure on an “already fragile and highly uncertain” market. Effective May 15, the French General Directorate for Food (DGAL) prohibited the sale of CBD gummies, tinctures and supplements under EU Novel Food regulation without prior consultation with industry representatives.

This year’s European NutraChampion is Dr. Ralf Jäger, an academic and innovative pioneer who has made game-changing contributions to the nutraceuticals industry.

Strategic innovation consultancy Qina has launched a Food Health Ecosystem to improve data insights for those operating in personalized nutrition, with the aim to improve access to real-world, long-term data and drive evidence-based innovation.

The functional mushroom supplement industry has a transparency problem, according to Mycogenius startup founder Seth Colchester, who says that misleading “third-party tested” claims and meaningless quality markers have become common place in the category.

New product launches across Europe in May 2026 reveal trends for innovating with creatine format and formulation, fibre for sugar and bloat reduction, and a focus on all-natural botanical blends.

The creators of next-gen dual encapsulation technology Optisolv enjoyed their premier exhibition at Vitafoods this year after seven years of working behind closed lab doors.

France has renewed the prohibition of food supplements containing Garcinia cambogia for an additional year as the European Council extends its consultation over the ingredient’s safety.

Polycystic Ovary Syndrome (PCOS) has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a ‘long overdue’ move described as a genuine opportunity for the health and nutrition industry.

Science-backed spinach extract Appethyl has taken a significant step towards health claim approval and is now available for acquisition by firms eager to compete in the GLP-1 market.